Table 2.
Adherence to study protocol in HiLo‐HF pilot randomized controlled trial
| All (n = 50) | High SpO2 target (n = 25) | Low SpO2 target (n = 25) | |
|---|---|---|---|
| % on determined SpO2 range ±1%, n (%) | |||
| 6 h | 27 (56.2) | 20 (83.3) | 7 (29.2) |
| 24 h | 25 (53.2) | 20 (87) | 5 (20.8) |
| 48 h | 25 (58.1) | 18 (85.7) | 7 (31.8) |
| 72 h | 18 (46.1) | 17 (94.4) | 1 (4.8) |
| % on O2, n (%) | |||
| 6 h | 27 (56.2) | 18 (75) | 9 (37.5) |
| 24 h | 18 (38.3) | 12 (52.2) | 6 (25) |
| 48 h | 17 (39.5) | 13 (61.9) | 4 (18.2) |
| 72 h | 16 (41) | 12 (66.6) | 4 (19) |
| O2 volume in pts treated with O2, L/min | |||
| 6 h | 2 (2, 3) | 2.5 (2, 4) | 2 (2, 3) |
| 24 h | 2.5 (2, 4) | 3 (2, 4) | 2 (1.3, 2.6) |
| 48 h | 2 (2, 3.5) | 2.5 (2, 4.7) | 2 (1.2, 3.1) |
| 72 h | 2.2 (1.1, 3.5) | 2.5 (1.6, 6.1) | 1.7 (1, 3.2) |
| Number of pts with SpO2 out of target range ±1% with inappropriate O2 volume, n (%) | |||
| 6 h | 7/48 (14.5) | 3/24 (12.5) | 4/24 (16.6) |
| 24 h | 9/48 (18.7) | 3/24 (12.5) | 6/24 (25) |
| 48 h | 3/43 (6.9) | 2/21 (9.5) | 1/22 (4.5) |
| 72 h | 4/39 (10.2) | 1/18 (5.5) | 3/21 (14.2) |
Note: HiLo, high‐dose oxygen/low‐dose oxygen; O2, oxygen; pts, patients; SpO2, peripheral oxygen saturation level.